| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/07/2023 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 432.8k | $4.01 | $1.7M | | 08/07/2023 |
| 07/02/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 52.5k | $7.72 | $405.3k | | 07/02/2018 |
| 05/25/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 6.2k | $7.97 | $49.5k | | 05/25/2018 |
| 01/03/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Exercise | Restricted Stock Units | 1.9k | $0.00 | $0 | | 01/03/2018 |
| 01/03/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Payment of Exercise | Common Stock | 706 | $9.79 | $6.9k | | 01/03/2018 |
| 01/02/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 22.5k | $9.23 | $207.7k | | 01/02/2018 |
| 01/02/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Restricted Stock Units | 12.5k | $0.00 | $0 | | 01/02/2018 |
| 12/11/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 17.1k | $9.33 | $159.7k | | 12/11/2017 |
| 11/27/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 6.2k | $9.89 | $61.4k | | 11/27/2017 |
| 05/25/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 6.3k | $12.24 | $77.3k | | 05/25/2017 |
| 01/03/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 13.5k | $13.89 | $187.5k | | 01/03/2017 |
| 01/03/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Restricted Stock Units | 7.5k | $0.00 | $0 | | 01/03/2017 |
| 11/28/2016 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 22.4k | $19.23 | $431.3k | | 11/25/2016 |
| 11/28/2016 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 600 | $19.85 | $11.9k | | 11/25/2016 |
| 11/25/2016 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 6.3k | $20.48 | $128.5k | | 11/25/2016 |
| 01/04/2016 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 60k | $19.00 | $1.1M | | 01/04/2016 |
| 11/24/2015 | BELLICUM PHARMACEUTICALS, INC | BLCM | Sale | Common Stock | 29.3k | $22.34 | $654.5k | | 11/24/2015 |
| 02/24/2015 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 60k | $23.47 | $1.4M | | 02/24/2015 |
| 12/18/2014 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 117.6k | $19.00 | $2.2M | | 12/18/2014 |
| 12/18/2014 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Common Stock | 117.6k | $0.00 | $0 | | 12/18/2014 |
| 10/17/2014 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Common Stock | 55k | $0.00 | $0 | | 10/17/2014 |
| 01/23/2014 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 55k | $4.74 | $260.7k | | 01/23/2014 |
| 01/17/2013 | CATALYST BIOSCIENCES, INC. | CBIO | Grant | Stock Option (Right to Buy) | 65k | $4.63 | $301k | | 01/17/2013 |
| 10/28/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Sale | Common Stock | 1.5k | $24.60 | $36.9k | | 10/26/2010 |
| 10/28/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 1.5k | $2.93 | $4.4k | | 10/26/2010 |
| 10/26/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 2k | $2.93 | $5.9k | | 10/26/2010 |
| 10/26/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Sale | Common Stock | 2k | $24.65 | $49.3k | | 10/26/2010 |
| 05/18/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Sale | Common Stock | 3.4k | $24.70 | $84.6k | | 05/17/2010 |
| 05/18/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 3.4k | $2.93 | $10k | | 05/17/2010 |
| 05/17/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 382 | $2.93 | $1.1k | | 05/17/2010 |
| 05/17/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 5.1k | $5.10 | $26k | | 05/17/2010 |
| 05/17/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 892 | $5.10 | $4.5k | | 05/17/2010 |
| 05/17/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Sale | Common Stock | 382 | $24.60 | $9.4k | | 05/17/2010 |
| 05/17/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Sale | Common Stock | 8.4k | $24.21 | $203.3k | | 05/17/2010 |
| 05/17/2010 | CATALYST BIOSCIENCES, INC. | CBIO | Exercise | Stock Option (Right to Buy) | 2.4k | $5.10 | $12.3k | | 05/17/2010 |
|